Fresh allegations of potential securities fraud have been leveled at Elon Musk over statements he recently made regarding the deaths of primates used for research at Neuralink, his biotech startup. Letters sent this afternoon to top officials at the US Securities and Exchange Commission (SEC) by a medical ethics group call on the agency to investigate Musk’s claims that monkeys who died during trials at the company were terminally ill and did not die as a result of Neuralink implants. They claim, based on veterinary records, that complications with the implant procedures led to their deaths.
Musk first acknowledged the deaths of the macaques on September 10 in a reply
→ Continue reading at WIRED
